SENISCA secures additional £3.7 million financing to support rapid development of senotherapeutic platform to treat age-related disease SENISCA secures additional £3.7 million financing to support rapid development of senotherapeutic platform to treat age-related disease £3.7 million seed financing supported by consortium of new and...